INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies: INFORM2 NivEnt.
Work
Year: 2019
Type: article
Source: Journal of Clinical Oncology
Authors Cornelis M. van Tilburg, Ruth Witt, Kristian W. Pajtler, Christoph Plass, Isabel Poschke +15 more
Institutions University Hospital Heidelberg, Hopp Children's Cancer Center Heidelberg, Heidelberg University, German Cancer Research Center, Epigenomics (Germany) +3 more
Cites:
Cited by: 5
Related to: 10
FWCI: 0.411
Citation percentile (by year/subfield): 55.35
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed